Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 280 followers
Latest posts
Last updated 4 days ago
Human medicines European public assessment report (EPAR): Teriparatide Sun, teriparatide, Date of authorisation: 18/11/2022, Revision: 4, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Teriparatide Sun, teriparatide, Date of...
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation: 26/06/2025, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Denbrayce, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Fulvestrant Mylan, fulvestrant, Date of authorisation: 08/01/2018, Revision: 7, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Fulvestrant Mylan, fulvestrant, Date of...
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation: 14/11/2018, Revision: 13, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Emgality, galcanezumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation: 20/05/2020, Revision: 9, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Zeposia, ozanimod, Date of authorisation...
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 12, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation...
Human medicines European public assessment report (EPAR): Adasuve, loxapine, Date of authorisation: 20/02/2013, Revision: 15, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Adasuve, loxapine, Date of authorisation...
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Tuznue, trastuzumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Memantine Accord, memantine, Date of authorisation: 03/12/2013, Revision: 8, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Memantine Accord, memantine, Date of...
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation: 26/06/2025, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 96, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Briumvi, ublituximab, Date of authorisation: 31/05/2023, Revision: 7, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Briumvi, ublituximab, Date of authorisation...